| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| GOSERELIN
| GOSERELIN | PROSTATE CANCER (THERAPEUTIC) | IMPLANTATION | Cmax 2.23 NANOMOLAR VD 20.3 LITER PPB 27.3 PERCENT Cl 9.78 LITER / HOUR HT 1.4 HOUR (EQN) SOLUBILITY SOLUBLE IN WATER | LUTROPIN-CHORIOGONADOTROPIC HORMONE RECEPTOR | GONADOTROPIN-RELEASING HORMONE RECEPTOR AGONIST CHEMBL1855 GONADOTROPIN-RELEASING HORMONE RECEPTOR P30968 GONADOTROPIN-RELEASING HORMONE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE SHORT PEPTIDE GNRH RECEPTOR | EMA | |||
